<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36009185</PMID><DateRevised><Year>2022</Year><Month>08</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-3921</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>8</Issue><PubDate><Year>2022</Year><Month>Jul</Month><Day>27</Day></PubDate></JournalIssue><Title>Antioxidants (Basel, Switzerland)</Title><ISOAbbreviation>Antioxidants (Basel)</ISOAbbreviation></Journal><ArticleTitle>Hydroxytyrosol Recovers SARS-CoV-2-PLpro-Dependent Impairment of Interferon Related Genes in Polarized Human Airway, Intestinal and Liver Epithelial Cells.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1466</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/antiox11081466</ELocationID><Abstract><AbstractText>The SARS-CoV-2 pandemic has caused approximately 6.3 million deaths, mainly due to the acute respiratory distress syndrome or multi-organ failure that characterizes COVID-19 acute disease. Post-acute COVID-19 syndrome, also known as long-COVID, is a condition characterized by a complex of symptoms that affects 10-20% of the individuals who have recovered from the infection. Scientific and clinical evidence demonstrates that long-COVID can develop in both adults and children. It has been hypothesized that multi-organ effects of long-COVID could be associated with the persistence of virus RNA/proteins in host cells, but the real mechanism remains to be elucidated. Therefore, we sought to determine the effects of the exogenous expression of the papain-like protease (PLpro) domain of the non-structural protein (NSP3) of SARS-CoV-2 in polarized human airway (Calu-3), intestinal (Caco-2), and liver (HepG2) epithelial cells, and to evaluate the ability of the natural antioxidant hydroxytyrosol (HXT) in neutralizing these effects. Our results demonstrated that PLpro was able to induce a cascade of inflammatory genes and proteins (mainly associated with the interferon pathway) and increase the apoptotic rate and expression of several oxidative stress markers in all evaluated epithelial cells. Noteably, the treatment with 10 &#x3bc;M HXT reverted PL-pro-dependent effects almost completely. This study provides the first evidence that SARS-CoV-2 PLpro remaining in host cells after viral clearance may contribute to the pathogenetic mechanisms of long-COVID. These effects may be counteracted by natural antioxidants. Further clinical and experimental studies are necessary to confirm this hypothesis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Crudele</LastName><ForeName>Annalisa</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Research Unit of Molecular Genetics of Complex Phenotypes, Bambino Ges&#xf9; Children's Hospital, IRCCS, 00146 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smeriglio</LastName><ForeName>Antonella</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-9756-304X</Identifier><AffiliationInfo><Affiliation>Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale Ferdinando Stagno d'Alcontres 31, 98166 Messina, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ingegneri</LastName><ForeName>Mariarosaria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale Ferdinando Stagno d'Alcontres 31, 98166 Messina, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Panera</LastName><ForeName>Nadia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Research Unit of Molecular Genetics of Complex Phenotypes, Bambino Ges&#xf9; Children's Hospital, IRCCS, 00146 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bianchi</LastName><ForeName>Marzia</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Research Unit of Molecular Genetics of Complex Phenotypes, Bambino Ges&#xf9; Children's Hospital, IRCCS, 00146 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Braghini</LastName><ForeName>Maria Rita</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Research Unit of Molecular Genetics of Complex Phenotypes, Bambino Ges&#xf9; Children's Hospital, IRCCS, 00146 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pastore</LastName><ForeName>Anna</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-0990-9419</Identifier><AffiliationInfo><Affiliation>Research Unit of Diagnostical and Management Innovations, Bambino Ges&#xf9; Children's Hospital, IRCCS, 00146 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tocco</LastName><ForeName>Valeria</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>FACS Unit, Bambino Ges&#xf9; Children's Hospital, IRCCS, 00146 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carsetti</LastName><ForeName>Rita</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>B Cell Research Unit, Bambino Ges&#xf9; Children's Hospital, IRCCS, 00146 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zaffina</LastName><ForeName>Salvatore</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-8858-5423</Identifier><AffiliationInfo><Affiliation>Occupational Medicine/Health Technology Assessment and Safety Research Unit, Clinical-Technological Innovations Research Area, Bambino Ges&#xf9; Children's Hospital, IRCCS, 00146 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alisi</LastName><ForeName>Anna</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-7241-6329</Identifier><AffiliationInfo><Affiliation>Research Unit of Molecular Genetics of Complex Phenotypes, Bambino Ges&#xf9; Children's Hospital, IRCCS, 00146 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trombetta</LastName><ForeName>Domenico</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale Ferdinando Stagno d'Alcontres 31, 98166 Messina, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>POR FESR 14/20</GrantID><Agency>Finpiemonte</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Antioxidants (Basel)</MedlineTA><NlmUniqueID>101668981</NlmUniqueID><ISSNLinking>2076-3921</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">cytokines</Keyword><Keyword MajorTopicYN="N">interferon</Keyword><Keyword MajorTopicYN="N">long-COVID</Keyword><Keyword MajorTopicYN="N">natural antioxidant</Keyword><Keyword MajorTopicYN="N">oxidative stress</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>7</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>26</Day><Hour>1</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>27</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>7</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36009185</ArticleId><ArticleId IdType="pmc">PMC9404978</ArticleId><ArticleId IdType="doi">10.3390/antiox11081466</ArticleId><ArticleId IdType="pii">antiox11081466</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sharma A., Tiwari S., Deb M.K., Marty J.L. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): A global pandemic and treatment strategies. Int. J. Antimicrob. Agents. 2020;56:106054. doi: 10.1016/j.ijantimicag.2020.106054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijantimicag.2020.106054</ArticleId><ArticleId IdType="pmc">PMC7286265</ArticleId><ArticleId IdType="pubmed">32534188</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu R., Zhao X., Li J., Niu P., Yang B., Wu H., Wang W., Song H., Huang B., Zhu N., et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding. Lancet. 2020;395:565&#x2013;574. doi: 10.1016/S0140-6736(20)30251-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30251-8</ArticleId><ArticleId IdType="pmc">PMC7159086</ArticleId><ArticleId IdType="pubmed">32007145</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang H., Rao Z. Structural biology of SARS-CoV-2 and implications for therapeutic development. Nat. Rev. Microbiol. 2021;19:685&#x2013;700. doi: 10.1038/s41579-021-00630-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-021-00630-8</ArticleId><ArticleId IdType="pmc">PMC8447893</ArticleId><ArticleId IdType="pubmed">34535791</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Liu Q., Guo D. Emerging coronaviruses: Genome structure, replication, and pathogenesis. J. Med. Virol. 2020;92:418&#x2013;423. doi: 10.1002/jmv.25681.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25681</ArticleId><ArticleId IdType="pmc">PMC7167049</ArticleId><ArticleId IdType="pubmed">31967327</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan S., Wu G. Spatial and temporal roles of SARS-CoV PLpro-A snapshot. FASEB J. 2021;35:e21197. doi: 10.1096/fj.202002271.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.202002271</ArticleId><ArticleId IdType="pmc">PMC7883198</ArticleId><ArticleId IdType="pubmed">33368679</ArticleId></ArticleIdList></Reference><Reference><Citation>Murgolo N., Therien A.G., Howell B., Klein D., Koeplinger K., Lieberman L.A., Adam G.C., Flynn J., McKenna P., Swaminathan G., et al. SARS-CoV-2 tropism, entry, replication, and propagation: Considerations for drug discovery and development. PLoS Pathog. 2021;17:e1009225. doi: 10.1371/journal.ppat.1009225.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1009225</ArticleId><ArticleId IdType="pmc">PMC7888651</ArticleId><ArticleId IdType="pubmed">33596266</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q., Zhang Y., Wu L., Niu S., Song C., Zhang Z., Lu G., Qiao C., Hu Y., Yuen K.-Y., et al. Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2. Cell. 2020;181:894&#x2013;904.e9. doi: 10.1016/j.cell.2020.03.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.03.045</ArticleId><ArticleId IdType="pmc">PMC7144619</ArticleId><ArticleId IdType="pubmed">32275855</ArticleId></ArticleIdList></Reference><Reference><Citation>Wanner N., Andrieux G., Badia-i-Mompel P., Edler C., Pfefferle S., Lindenmeyer M.T., Schmidt-Lauber C., Czogalla J., Wong M.N., Okabayashi Y., et al. Molecular consequences of SARS-CoV-2 liver tropism. Nat. Metab. 2022;4:310&#x2013;319. doi: 10.1038/s42255-022-00552-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42255-022-00552-6</ArticleId><ArticleId IdType="pmc">PMC8964418</ArticleId><ArticleId IdType="pubmed">35347318</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu B., Guo H., Zhou P., Shi Z.L. Characteristics of SARS-CoV-2 and COVID-19. Nat. Rev. Microbiol. 2021;19:141&#x2013;154. doi: 10.1038/s41579-020-00459-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-020-00459-7</ArticleId><ArticleId IdType="pmc">PMC7537588</ArticleId><ArticleId IdType="pubmed">33024307</ArticleId></ArticleIdList></Reference><Reference><Citation>Grasselli G., Zangrillo A., Zanella A., Antonelli M., Cabrini L., Castelli A., Cereda D., Coluccello A., Foti G., Fumagalli R., et al. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020;323:1574&#x2013;1581. doi: 10.1001/jama.2020.5394.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.5394</ArticleId><ArticleId IdType="pmc">PMC7136855</ArticleId><ArticleId IdType="pubmed">32250385</ArticleId></ArticleIdList></Reference><Reference><Citation>Fara A., Mitrev Z., Rosalia R.A., Assas B.M. Cytokine storm and COVID-19: A chronicle of pro-inflammatory cytokines. Open Biol. 2020;10:200160. doi: 10.1098/rsob.200160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsob.200160</ArticleId><ArticleId IdType="pmc">PMC7536084</ArticleId><ArticleId IdType="pubmed">32961074</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., Cook J.R., Nordvig A.S., Shalev D., Sehrawat T.S., et al. Post-acute COVID-19 syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C., Haupert S.R., Zimmermann L., Shi X., Fritsche L.G., Mukherjee B. Global Prevalence of Post COVID-19 Condition or Long COVID: A Meta-Analysis and Systematic Review. J. Infect. Dis. 2022;6:jiac136. doi: 10.1093/infdis/jiac136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Coronavirus Disease (COVID-19): Post COVID-19 Condition.  [(accessed on 19 May 2022)]; Available online:  https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-(COVID-19)-post-COVID-19-condition.</Citation></Reference><Reference><Citation>Nittas V., Gao M., West E.A., Ballouz T., Menges D., Wulf Hanson S., Puhan M.A. Long COVID Through a Public Health Lens: An Umbrella Review. Public Health Rev. 2022;43:1604501. doi: 10.3389/phrs.2022.1604501.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/phrs.2022.1604501</ArticleId><ArticleId IdType="pmc">PMC8963488</ArticleId><ArticleId IdType="pubmed">35359614</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaebler C., Wang Z., Lorenzi J.C.C., Muecksch F., Finkin S., Tokuyama M., Cho A., Jankovic M., Schaefer-Babajew D., Oliveira T.Y., et al. Evolution of antibody immunity to SARS-CoV-2. Nature. 2021;591:639&#x2013;644. doi: 10.1038/s41586-021-03207-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03207-w</ArticleId><ArticleId IdType="pmc">PMC8221082</ArticleId><ArticleId IdType="pubmed">33461210</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall M. The four most urgent questions about long COVID. Nature. 2021;594:168&#x2013;170. doi: 10.1038/d41586-021-01511-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-021-01511-z</ArticleId><ArticleId IdType="pubmed">34108700</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarrott B., Head R., Pringle K.G., Lumbers E.R., Martin J.H. &#x201c;LONG COVID&#x201d;&#x2014;A hypothesis for understanding the biological basis and pharmacological treatment strategy. Pharmacol. Res. Perspect. 2022;10:e00911. doi: 10.1002/prp2.911.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prp2.911</ArticleId><ArticleId IdType="pmc">PMC8929332</ArticleId><ArticleId IdType="pubmed">35029046</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamboj A., Saluja A.K., Kumar M., Atri P. Antiviral activity of plant polyphenols. J. Pharm. Res. 2012;5:2402&#x2013;2412.</Citation></Reference><Reference><Citation>Karkovi&#x107; Markovi&#x107; A., Tori&#x107; J., Barbari&#x107; M., Jakobu&#x161;i&#x107; Brala C. Hydroxytyrosol, Tyrosol and Derivatives and Their Potential Effects on Human Health. Molecules. 2019;24:2001. doi: 10.3390/molecules24102001.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules24102001</ArticleId><ArticleId IdType="pmc">PMC6571782</ArticleId><ArticleId IdType="pubmed">31137753</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamada K., Ogawa H., Hara A., Yoshida Y., Yonezawa Y., Karibe K., Nghia V.B., Yoshimura H., Yamamoto Y., Yamada M., et al. Mechanism of the antiviral effect of hydroxytyrosol on influenza virus appears to involve morphological change of the virus. Antivir. Res. 2009;83:35&#x2013;44. doi: 10.1016/j.antiviral.2009.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2009.03.002</ArticleId><ArticleId IdType="pubmed">19501255</ArticleId></ArticleIdList></Reference><Reference><Citation>Fabregat A., Sidiropoulos K., Garapati P., Gillespie M., Hausmann K., Haw R., Jassal B., Jupe S., Korninger F., McKay S., et al. The Reactome pathway Knowledgebase. Nucleic Acids Res. 2016;44:D481&#x2013;D487. doi: 10.1093/nar/gkv1351.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkv1351</ArticleId><ArticleId IdType="pmc">PMC4702931</ArticleId><ArticleId IdType="pubmed">26656494</ArticleId></ArticleIdList></Reference><Reference><Citation>Panera N., Gnani D., Piermarini E., Petrini S., Bertini E., Nobili V., Pastore A., Piemonte F., Alisi A. High concentrations of H2O2 trigger hypertrophic cascade and phosphatase and tensin homologue (PTEN) glutathionylation in H9c2 cardiomyocytes. Exp. Mol. Pathol. 2016;100:199&#x2013;206. doi: 10.1016/j.yexmp.2016.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexmp.2016.01.001</ArticleId><ArticleId IdType="pubmed">26772165</ArticleId></ArticleIdList></Reference><Reference><Citation>Smeriglio A., De Francesco C., Denaro M., Trombetta D. Prickly Pear Betalain-Rich Extracts as New Promising Strategy for Intestinal Inflammation: Plant Complex vs. Main Isolated Bioactive Compounds. Front. Pharmacol. 2021;12:722398. doi: 10.3389/fphar.2021.722398.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.722398</ArticleId><ArticleId IdType="pmc">PMC8476807</ArticleId><ArticleId IdType="pubmed">34594220</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S., Zhang Y., Guan Z., Li H., Ye M., Chen X., Shen J., Zhou Y., Shi Z.L., Zhou P., et al. SARS-CoV-2 triggers inflammatory responses and cell death through caspase-8 activation. Signal Transduct. Target. Ther. 2020;5:235. doi: 10.1038/s41392-020-00334-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-020-00334-0</ArticleId><ArticleId IdType="pmc">PMC7545816</ArticleId><ArticleId IdType="pubmed">33037188</ArticleId></ArticleIdList></Reference><Reference><Citation>Silvagno F., Vernone A., Pescarmona G.P. The Role of Glutathione in Protecting against the Severe Inflammatory Response Triggered by COVID-19. Antioxidants. 2020;9:624. doi: 10.3390/antiox9070624.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox9070624</ArticleId><ArticleId IdType="pmc">PMC7402141</ArticleId><ArticleId IdType="pubmed">32708578</ArticleId></ArticleIdList></Reference><Reference><Citation>Forcados G.E., Muhammad A., Oladipo O.O., Makama S., Meseko C.A. Metabolic Implications of Oxidative Stress and Inflammatory Process in SARS-CoV-2 Pathogenesis: Therapeutic Potential of Natural Antioxidants. Front. Cell Infect. Microbiol. 2021;11:654813. doi: 10.3389/fcimb.2021.654813.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.654813</ArticleId><ArticleId IdType="pmc">PMC8188981</ArticleId><ArticleId IdType="pubmed">34123871</ArticleId></ArticleIdList></Reference><Reference><Citation>da Rosa Mesquita R., Francelino Silva Junior L.C., Santos Santana F.M., Farias de Oliveira T., Campos Alc&#xe2;ntara R., Monteiro Arnozo G., Rodrigues da Silva Filho E., Galdino Dos Santos A.G., Oliveira da Cunha E.J., Salgueiro de Aquino S.H., et al. Clinical manifestations of COVID-19 in the general population: Systematic review. Wien. Klin. Wochenschr. 2021;133:377&#x2013;382. doi: 10.1007/s00508-020-01760-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00508-020-01760-4</ArticleId><ArticleId IdType="pmc">PMC7689634</ArticleId><ArticleId IdType="pubmed">33242148</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Li Y., Liu Q., Yao Q., Wang X., Zhang H., Chen R., Ren L., Min J., Deng F., et al. SARS-CoV-2 cell tropism and multiorgan infection. Cell Discov. 2021;7:17. doi: 10.1038/s41421-021-00249-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41421-021-00249-2</ArticleId><ArticleId IdType="pmc">PMC7987126</ArticleId><ArticleId IdType="pubmed">33758165</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson B.K., Francisco E.B., Yogendra R., Long E., Pise A., Rodrigues H., Hall E., Herrera M., Parikh P., Guevara-Coto J., et al. Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection. Front. Immunol. 2022;12:746021. doi: 10.3389/fimmu.2021.746021.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.746021</ArticleId><ArticleId IdType="pmc">PMC8784688</ArticleId><ArticleId IdType="pubmed">35082777</ArticleId></ArticleIdList></Reference><Reference><Citation>Zollner A., Koch R., Jukic A., Pfister A., Meyer M., R&#xf6;ssler A., Kimpel J., Adolph T.E., Tilg H. Postacute COVID-19 is Characterized by Gut Viral Antigen Persistence in Inflammatory Bowel Diseases. Gastroenterology. 2022;1:S0016-5085(22)00450-4. doi: 10.1053/j.gastro.2022.04.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2022.04.037</ArticleId><ArticleId IdType="pmc">PMC9057012</ArticleId><ArticleId IdType="pubmed">35508284</ArticleId></ArticleIdList></Reference><Reference><Citation>Santerre M., Arjona S.P., Allen C.N., Shcherbik N., Sawaya B.E. Why do SARS-CoV-2 NSPs rush to the ER? J. Neurol. 2021;268:2013&#x2013;2022. doi: 10.1007/s00415-020-10197-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-10197-8</ArticleId><ArticleId IdType="pmc">PMC7461160</ArticleId><ArticleId IdType="pubmed">32870373</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin D., Mukherjee R., Grewe D., Bojkova D., Baek K., Bhattacharya A., Schulz L., Widera M., Mehdipour A.R., Tascher G., et al. Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity. Nature. 2020;587:657&#x2013;662. doi: 10.1038/s41586-020-2601-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2601-5</ArticleId><ArticleId IdType="pmc">PMC7116779</ArticleId><ArticleId IdType="pubmed">32726803</ArticleId></ArticleIdList></Reference><Reference><Citation>Munnur D., Teo Q., Eggermont D., Lee H.H.Y., Thery F., Ho J., van Leur S.W., Ng W.W.S., Siu L.Y.L., Beling A., et al. Altered ISGylation drives aberrant macrophage-dependent immune responses during SARS-CoV-2 infection. Nat. Immunol. 2021;22:1416&#x2013;1427. doi: 10.1038/s41590-021-01035-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01035-8</ArticleId><ArticleId IdType="pubmed">34663977</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal A.D., VanElzakker M.B. Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms. Front. Microbiol. 2021;12:698169. doi: 10.3389/fmicb.2021.698169.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong L.A., Lange S.M., Dee Cesare V., Matthews S.P., Nirujogi R.S., Cole I., Hope A., Cunningham F., Toth R., Mukherjee R., et al. Biochemical characterization of protease activity of Nsp3 from SARS-CoV-2 and its inhibition by nanobodies. PLoS ONE. 2021;16:e0253364. doi: 10.1371/journal.pone.0253364.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0253364</ArticleId><ArticleId IdType="pmc">PMC8284666</ArticleId><ArticleId IdType="pubmed">34270554</ArticleId></ArticleIdList></Reference><Reference><Citation>Narayanan A., Narwal M., Majowicz S.A., Varricchio C., Toner S.A., Ballatore C., Brancale A., Murakami K.S., Jose J. Identification of SARS-CoV-2 inhibitors targeting Mpro and PLpro using in-cell-protease assay. Commun. Biol. 2022;5:169. doi: 10.1038/s42003-022-03090-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-022-03090-9</ArticleId><ArticleId IdType="pmc">PMC8881501</ArticleId><ArticleId IdType="pubmed">35217718</ArticleId></ArticleIdList></Reference><Reference><Citation>Yapasert R., Khaw-On P., Banjerdpongchai R. Coronavirus Infection-Associated Cell Death Signaling and Potential Therapeutic Targets. Molecules. 2021;26:7459. doi: 10.3390/molecules26247459.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules26247459</ArticleId><ArticleId IdType="pmc">PMC8706825</ArticleId><ArticleId IdType="pubmed">34946543</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren Y., Shu T., Wu D., Mu J., Wang C., Huang M., Han Y., Zhang X.Y., Zhou W., Qiu Y., et al. The ORF3a protein of SARS-CoV-2 induces apoptosis in cells. Cell Mol. Immunol. 2020;17:881&#x2013;883. doi: 10.1038/s41423-020-0485-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-020-0485-9</ArticleId><ArticleId IdType="pmc">PMC7301057</ArticleId><ArticleId IdType="pubmed">32555321</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin C.W., Lin K.H., Hsieh T.H., Shiu S.Y., Li J.Y. Severe acute respiratory syndrome coronavirus 3C-like protease-induced apoptosis. FEMS Immunol. Med. Microbiol. 2006;46:375&#x2013;380. doi: 10.1111/j.1574-695X.2006.00045.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1574-695X.2006.00045.x</ArticleId><ArticleId IdType="pmc">PMC7110344</ArticleId><ArticleId IdType="pubmed">16553810</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang H., Yang P., Zhang J. Potential Inhibitors Targeting Papain-like Protease of SARS-CoV-2: Two Birds with One Stone. Front. Chem. 2022;10:822785. doi: 10.3389/fchem.2022.822785.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fchem.2022.822785</ArticleId><ArticleId IdType="pmc">PMC8905519</ArticleId><ArticleId IdType="pubmed">35281561</ArticleId></ArticleIdList></Reference><Reference><Citation>Calleja D.J., Lessene G., Komander D. Inhibitors of SARS-CoV-2 PLpro. Front. Chem. 2022;10:876212. doi: 10.3389/fchem.2022.876212.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fchem.2022.876212</ArticleId><ArticleId IdType="pmc">PMC9086436</ArticleId><ArticleId IdType="pubmed">35559224</ArticleId></ArticleIdList></Reference><Reference><Citation>Vollbracht C., Kraft K. Oxidative Stress and Hyper-Inflammation as Major Drivers of Severe COVID-19 and Long COVID: Implications for the Benefit of High-Dose Intravenous Vitamin, C. Front. Pharmacol. 2022;13:899198. doi: 10.3389/fphar.2022.899198.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.899198</ArticleId><ArticleId IdType="pmc">PMC9100929</ArticleId><ArticleId IdType="pubmed">35571085</ArticleId></ArticleIdList></Reference><Reference><Citation>Guloyan V., Oganesian B., Baghdasaryan N., Yeh C., Singh M., Guilford F., Ting Y.S., Venketaraman V. Glutathione Supplementation as an Adjunctive Therapy in COVID-19. Antioxidants. 2020;9:914. doi: 10.3390/antiox9100914.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox9100914</ArticleId><ArticleId IdType="pmc">PMC7601802</ArticleId><ArticleId IdType="pubmed">32992775</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartolini D., Stabile A.M., Bastianelli S., Giustarini D., Pierucci S., Busti C., Vacca C., Gidari A., Francisci D., Castronari R., et al. SARS-CoV2 infection impairs the metabolism and redox function of cellular glutathione. Redox. Biol. 2021;45:102041. doi: 10.1016/j.redox.2021.102041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2021.102041</ArticleId><ArticleId IdType="pmc">PMC8190457</ArticleId><ArticleId IdType="pubmed">34146958</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu R., Chen L., Lan R., Shen R., Li P. Computational Screening of Antagonists against the SARS-CoV-2 (COVID-19) Coronavirus by Molecular Docking. Int. J. Antimicrob. Agents. 2020;56:106012. doi: 10.1016/j.ijantimicag.2020.106012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijantimicag.2020.106012</ArticleId><ArticleId IdType="pmc">PMC7205718</ArticleId><ArticleId IdType="pubmed">32389723</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeda Y., Jamsransuren D., Matsuda S., Crea R., Ogawa H. The SARS-CoV-2-Inactivating Activity of Hydroxytyrosol-Rich Aqueous Olive Pulp Extract (HIDROX&#xae;) and Its Use as a Virucidal Cream for Topical Application. Viruses. 2021;13:232. doi: 10.3390/v13020232.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13020232</ArticleId><ArticleId IdType="pmc">PMC7913061</ArticleId><ArticleId IdType="pubmed">33540713</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva S., Sepodes B., Rocha J., Direito R., Fernandes A., Brites D., Freitas M., Fernandes E., Bronze M.R., Figueira M.E. Protective effects of hydroxytyrosol-supplemented refined olive oil in animal models of acute inflammation and rheumatoid arthritis. J. Nutr. Biochem. 2015;26:360&#x2013;368. doi: 10.1016/j.jnutbio.2014.11.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jnutbio.2014.11.011</ArticleId><ArticleId IdType="pubmed">25620693</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartolomei M., Bollati C., Bellumori M., Cecchi L., Cruz-Chamorro I., Santos-S&#xe1;nchez G., Ranaldi G., Ferruzza S., Sambuy Y., Arnoldi A., et al. Extra Virgin Olive Oil Phenolic Extract on Human Hepatic HepG2 and Intestinal Caco-2 Cells: Assessment of the Antioxidant Activity and Intestinal Trans-Epithelial Transport. Antioxidants. 2021;10:118. doi: 10.3390/antiox10010118.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox10010118</ArticleId><ArticleId IdType="pmc">PMC7829860</ArticleId><ArticleId IdType="pubmed">33467632</ArticleId></ArticleIdList></Reference><Reference><Citation>Mosca A., Crudele A., Smeriglio A., Braghini M.R., Panera N., Comparcola D., Alterio A., Sartorelli M.R., Tozzi G., Raponi M., et al. Antioxidant activity of Hydroxytyrosol and Vitamin E reduces systemic inflammation in children with paediatric NAFLD. Dig. Liver Dis. 2021;53:1154&#x2013;1158. doi: 10.1016/j.dld.2020.09.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dld.2020.09.021</ArticleId><ArticleId IdType="pubmed">33060043</ArticleId></ArticleIdList></Reference><Reference><Citation>Silvan J.M., Guerrero-Hurtado E., Guti&#xe9;rrez-Docio A., Alarc&#xf3;n-Cavero T., Prodanov M., Martinez-Rodriguez A.J. Olive-Leaf Extracts Modulate Inflammation and Oxidative Stress Associated with Human H. pylori Infection. Antioxidants. 2021;10:2030. doi: 10.3390/antiox10122030.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox10122030</ArticleId><ArticleId IdType="pmc">PMC8698654</ArticleId><ArticleId IdType="pubmed">34943133</ArticleId></ArticleIdList></Reference><Reference><Citation>Esposito S., Principi N., Azzari C., Cardinale F., Di Mauro G., Galli L., Gattinara G.C., Fainardi V., Guarino A., Lancella L., et al. Italian intersociety consensus on management of long covid in children. Ital. J. Pediatr. 2022;8:42. doi: 10.1186/s13052-022-01233-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13052-022-01233-6</ArticleId><ArticleId IdType="pmc">PMC8905554</ArticleId><ArticleId IdType="pubmed">35264214</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>